Press Releases
BioCity Scotland joins forces with Harrison Goddard Foote
BioCity Scotland, the newly-opened life sciences cluster in Newhouse, Lanarkshire, has signed a three-year agreement with leading patent attorneys HGF making them the first corporate partner to join the BioCity team. The two organisations share a...
Press Releases
BHMS Investments Acquires Osmotics
BHMS Investments, LP, through affiliated funds, completed the acquisition of Osmotics Corporation , a boutique producer of science-based anti-aging skincare products. Osmotics is an industry leader in the advanced skincare market or cosmeceuticals, which it helped pioneer upon...
Press Releases
European Commission approves Esmya® for the pre-operative treatment of uterine fibroids
Gedeon Richter Plc. announced today that the European Commission has granted marketing authorization to Esmya® 5mg tablet as pre-operative treatment of moderate to severe symptoms of uterine fibroids. This decision follows positive opinion from...
Press Releases
FDA Grants Orphan Drug Status for CF102 for the Treatment of Hepatocellular Carcinoma to Can-Fite BioPharma
Can-Fite BioPharma Ltd , a biotechnology company developing small molecule drugs for the treatment of inflammatory, and liver diseases, traded on the Tel Aviv Stock Exchange, announced today that the US Food and Drug Administration has granted Orphan...
Press Releases
ELC Group launches new software subsidiary Pharma eReport to provide complete EVMPD compliance solution
ELC Group, the pan-European pharmaceutical regulatory affairs organisation, today announces the launch of a new subsidiary, Pharma eReport – a software and services company that delivers a comprehensive EVMPD compliance solution for pharmaceutical regulatory professionals. ...
Press Releases
Provepharm announces impressive trading and financial results for 2011
Provepharm, which is specialized in the development of pharmaceutical applications, announces today very healthy trading and financial results for 2011. The company broke even for the first time last year, when its revenues amounted to EUR three million. ...
Press Releases
DNA Electronics CEO Professor Chris Toumazou To Address Scripps “Future of Genomic Medicine” Conference
DNA Electronics Ltd. a developer of semiconductor solutions for real-time DNA and RNA detection, today announces that DNA Electronics Chairman and CEO Professor Chris Toumazou FRS will be an invited speaker at the upcoming “The Future of Genomic Medicine...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read
















